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Abstract
Background Older patients often have multiple comorbidities and are susceptible to develop intercurrent diseases during 
rehabilitation. This study investigates intercurrent diseases and associated factors in patients undergoing geriatric stroke 
rehabilitation, focussing on pre-existing comorbid conditions, overall comorbidity and baseline functional status.
Materials and methods This multicentre prospective cohort study included 15 skilled nursing facilities. Data were collected 
at baseline and at discharge. The primary outcome measures were presence and number of intercurrent diseases. Further-
more, their impact on change in rehabilitation goals or length of stay was examined. Comorbidity was assessed with the 
Charlson index, and functional status with the Barthel index (BI).
Results Of the 175 included patients, 51% developed an intercurrent disease. A lower baseline BI, a higher Charlson index, 
presence of diabetes mellitus (DM) and kidney disease were related to the occurrence of an intercurrent disease (p < 0.05). 
Moreover, a lower BI, a higher Charlson index, and particularly the presence of DM were independently associated. If both 
comorbidity and a lower baseline functional status were present, the odds ratio (95% CI) of developing intercurrent diseases 
was 6.70 [2.33–19.2], compared to 1.73 [0.52–5.72] (comorbidity only) and 1.62 [0.53–4.94] (only BI ≤ 14).
Conclusions On admission, functional impairments and comorbidity, particularly diabetes, independently contribute to 
developing intercurrent diseases during geriatric stroke rehabilitation. Therefore, routine evaluation of comorbidity integrated 
with functional status at the start of rehabilitation is essential to identify patients at risk. Finally, particular attention should 
be paid to patients with DM to prevent intercurrent diseases and support optimal functional recovery .
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Introduction
Following acute hospitalisation, rehabilitation helps patients 
to regain functional independency that enables them to be 
discharged home. However, during hospitalisation, the 
risk of functional decline and complications is particularly 
increased in older patients [1]. In the Netherlands, about 
one-third of all stroke patients are referred to a skilled nurs-
ing facility (SNF) that provides geriatric rehabilitation. 
These patients are usually relatively older, have a longer 
length of stay (LoS) in the acute hospital, and have more 
complex problems (Supplement material Appendix A) [2]. 
Also, during inpatient rehabilitation, intercurrent diseases 
may occur that interfere with therapy and could negatively 
impact rehabilitation outcome [3, 4].
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Studies investigating complications during inpatient 
stroke rehabilitation found that 30–96% of the patients 
developed complications; this wide range could be due to 
different definitions of a complication and the methods of 
measurement [5–12]. The present study investigates inter-
current diseases, i.e. any disease that occurs during the 
progress of another disease, during rehabilitation. Factors 
related to intercurrent diseases can include age, gender [9, 
13], time interval between stroke and rehabilitation [7, 10, 
12], severe stroke [7, 11] or functional impairment [6, 9, 12, 
13] and comorbidity [5–7, 13, 14], although it is unknown 
which specific comorbidities are related. Particularly, older 
patients are at risk of functional decline and often have mul-
tiple comorbidities. However, few studies have investigated 
associations with intercurrent diseases in the older, vulner-
able group of patients receiving geriatric stroke rehabilita-
tion [5, 13]. Furthermore, intercurrent diseases may impede 
successful functional recovery [5, 14]. Therefore, to better 
understand the relations between comorbidity, functional 
impairment and intercurrent diseases, and to identify asso-
ciated pre-existing comorbid conditions, this study explores: 
(i) the presence, and number of intercurrent diseases and 
their impact on older patients admitted to an SNF, recover-
ing after stroke, and (ii) factors associated with the presence 




Data were obtained from the Geriatric Rehabilitation in 
AMPutation and Stroke (GRAMPS) study. Data collection 
took place between January 2008 and July 2010; details 
on the study design are already published [15]. A total of 
15 SNFs located in the southern part of the Netherlands 
participated. All stroke patients admitted to one of these 
SNFs were eligible for inclusion. Patients were excluded 
if they refused participation, were unable to give informed 
consent, were critically ill, or were expected to have a stay 
of ≤ 2 weeks. The medical ethics committee of the region 
Nijmegen-Arnhem approved the study protocol.
Outcome measures
For the present study, the outcome measures were: the pres-
ence and number of intercurrent diseases that occurred dur-
ing rehabilitation. Intercurrent diseases were coded using 
the 10th revision Clinical Modification ICD-10CM. At dis-
charge, the attending physician registered intercurrent dis-
eases that affected the course of the rehabilitation: impact 
was classified according to (i) whether the disease had 
prolonged the LoS or (ii) whether the rehabilitation goals 
needed adjustment. Four categories were formed: (1) no 
intercurrent disease, (2) ‘No impact’, (3) ‘With impact’, and 
(4) intercurrent disease that directly caused death.
Data collection
The participating multidisciplinary teams consisted of a 
physician [16], a physiotherapist, an occupational therapist, 
a psychologist, a speech therapist, a dietician and skilled 
nurses; all received the same instructions regarding perfor-
mance of the assessments. Data were collected within the 
first 2 weeks after admission (T0) and at discharge (T1) from 
the SNF or (at the latest) 1 year after admission, if a patient 
was still in the SNF at that time.
Measurements
The following patient characteristics and data were col-
lected: age, gender, home situation, comorbidity, LoS in 
acute hospital, LoS in the SNF, and discharge destination 
[5–14, 17]. Functional assessment was performed at base-
line and at discharge using the modified Barthel index (BI) 
to assess activities of daily living (ADL) [18]. Premorbid 
BI was assessed on admission, using information on the 
patient’s situation prior to the acute stroke, based on inter-
view and collateral history. Functional recovery was defined 
in two ways: BI at discharge and ‘relative functional gain’, 
which was calculated as follows: (BI-discharge minus BI-
admission)/(BI-premorbid minus BI-admission) × 100 [19, 
20]. Relative functional gain expresses the achieved percent-
age of potential functional gain.
Pre-existing comorbidity was assessed using the Charl-
son comorbidity index (Charlson-CI). This index consists 
of 19 diagnoses and was adjusted for stroke [21–23]. The 
Charlson-CI was categorised as: 0 (no comorbidity), 1 (sin-
gle comorbidity) or ≥ 2 (multiple comorbidities), unless oth-
erwise specified. Comorbidities were recorded if present in 
medical history, e.g. chronic diseases and conditions that 
required ongoing use of (preventive) medication. Conditions 
that had completely resolved without any residual symp-
toms or need for treatment were not noted (e.g. childhood 
asthma). Finally, if myocardial infarction in the past had led 
to heart failure, only heart failure was recorded.
Statistical analysis
Data were processed and analysed using the Statistical Pack-
age for Social Science version 23. Means with standard 
deviations (normal distribution), medians with interquartile 
ranges (skewed data), or absolute numbers with percentages 
(categorical data) are reported.
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A Chi-Squared test (categorical data), ANOVA or 
Kruskal–Wallis test, depending on their distribution, 
were used to detect mean differences in characteristics 
between the four intercurrent disease categories and to 
identify comorbid conditions related to the occurrence of 
intercurrent diseases. A p value of ≤ 0.05 was considered 
statistically significant.
Multivariate analyses were performed using binary 
logistic regression with the presence of intercurrent dis-
eases and Poisson regression with number of intercur-
rent diseases as the dependent variable. Rehabilitation 
LoS (log) was added as the ‘offset’. Factors included in 
the multivariate model were age and gender. Significant 
baseline variables (p < 0.10) were added as a continuous 
variable if applicable.
Before performing the analyses, data were tested for 
the required assumptions, such as multicollinearity, inter-
action and effect modification. To investigate comorbid-
ity and baseline functional status, separate and combined 
relations with the presence of intercurrent diseases were 
analysed. For this purpose, variables were dichotomized. 
Odds ratios (OR) were calculated with the absence of both 
factors as reference category [24]. Sensitivity analyses 
were performed, i.e. with and without deceased patients.
Results
Characteristics
Of the 378 eligible patients, 186 were included in the 
GRAMPS study; the excluded patients did not differ 
with regard to age, gender or LoS [25]. The present study 
included 175 patients because 11 patients were lost to 
follow-up, mainly due to translocation to another SNF 
(Supplement material Appendices B and C). Table 1 pre-
sents the baseline characteristics of the study population, 
and the intercurrent disease categories. Mean age was 
78.8 years and 46% were males. On average, LoS in the 
acute hospital was 19 days, the premorbid BI was 20, 
baseline BI was 12, and BI at discharge was 17. LoS in 
the SNF was 12 weeks, the (average) relative functional 
gain was 67, and 56% of these patients was discharged 
home.
Of the 89 (51%) patients that developed an intercurrent 
disease, 49% developed one disease, 33% ≥ 2 diseases, 
and 18% died. Comorbidity was present in 116 (62%) 
patients: 40 (21%) scored 1 and 76 (41%) scored ≥ 2. The 
most prevalent pre-existing comorbidities were myocar-
dial infarction (18%), diabetes mellitus (18%) and conges-
tive heart failure (16%).
Characteristics related to intercurrent diseases
Patients without any intercurrent disease had a BI on admis-
sion of at least 4 points higher than those with intercurrent 
diseases. The proportion of patients without comorbidity was 
largest in the category ‘no intercurrent disease’ (52%), whereas 
in the category ‘With impact’, the proportion of patients with 
multiple comorbidities was the largest (54%), p = 0.007. 
Patients that developed intercurrent diseases were less often 
discharged home, had a longer LoS, a lower BI at discharge, 
and a lower relative functional gain. This also applied to the 
category that was considered as having ‘No impact’. Mul-
tivariate analyses showed that: BI on admission (OR 0.87 
[0.82–0.92]) and comorbidity (OR 1.43 [1.13–1.81]) were 
independently associated with the presence of intercurrent 
diseases, but only the Charlson-CI was significantly associated 
with number of intercurrent diseases (incidence rate ratio: 1.14 
[1.03–1.25], p: 0.008). This means that with every extra point 
on the Charlson-CI, a 14% increase in the number of intercur-
rent diseases is expected (Supplement material Appendix D).
Comorbidity and intercurrent diseases
Having diabetes and/or kidney disease was significantly related 
to the occurrence of an intercurrent disease (Table 2). More-
over, logistic regression analysis showed that only diabetes 
was independently associated (OR 3.50 [1.32–9.26]). No clear 
patterns or relations between comorbidities and specific inter-
current diseases were observed: a wide variety of different 
diseases occurred in patients with pre-existing comorbidity. 
The intercurrent diseases that most frequently occurred were 
cardiovascular (13%), psychiatric (12%) such as depression 
and delirium, and genitourinary (11%), predominantly uri-
nary tract infections. An overview of intercurrent diseases, 
per comorbidity (the five most prevalent only), is presented in 
Supplement material Appendix E.
Comorbidity and baseline functional status
Table 3 shows the cumulative effect of the combination of a 
lower functional status on admission (BI ≤ 14) and the pres-
ence of comorbidity (Charlson-CI ≥ 1) in relation to the occur-
rence of an intercurrent disease. On admission, when comor-
bidity and lower functional status on admission were present 
separately, ORs were 1.73 [0.52–5.72] and 1.62 [0.53–4.94], 
respectively. However, if both were present, the OR was 6.70 
[2.33–19.2].




To our knowledge, this is the first study to focus on comor-
bidity and intercurrent diseases during geriatric stroke reha-
bilitation. The study cohort was characterised by a large drop 
in functional status after acute stroke, often with multiple 
comorbidities and a higher age compared to the majority 
of studies on stroke patients [5–10, 12–14, 26]. Although 
this subgroup had been triaged for inpatient geriatric reha-
bilitation, and selected as a vulnerable subgroup of patients 
on the base of medical complexity and functional depend-
ency, discriminant factors were still present. Lower baseline 
functional status, higher pre-existing comorbidity burden in 
general and specifically the presence of diabetes mellitus 
were independent determinants of developing intercurrent 
diseases. Furthermore, patients with multiple comorbidi-
ties (higher Charlson-CI) had an increased risk to develop a 
higher number of intercurrent diseases. Finally, the odds of 
developing an intercurrent disease were substantially higher 
if a patient had both comorbidity and functional impairment 
than if only one of these factors were present.
Intercurrent diseases
The percentage of patients (51%) that developed inter-
current diseases is comparable to that of studies using an 
Table 1  Patient characteristics classified by intercurrent disease (ID) impact category
Equal statistical significance was found when deceased patients were excluded
SD standard deviation, Charlson-CI Charlson comorbidity index, IQR interquartile range, LoS length of stay
Statistical significance at p < 0.05
*Kruskal–Wallis test
# Chi-Square test
Total baseline  
n = 175
ID absent  
n = 86
ID no impact  
n = 22
ID with impact  
n = 46






Age (years), Mean 
(SD)
78.8 (8.0) 78.2 (8.3) 78.8 (5.6) 78.9 (8.5) 81.2 (8.4) 82.6 (7.8)
Gender (male), n (%) 80 (46) 45 (52) 11 (50) 16 (35) 7 (44) 1 (20)
Charlson-CI score, 
median (IQR)
1 (2)* 0 (2) 1 (2) 2 (2) 2 (2) 2 (3)
Charlson-CI = 0, n 
(%)
68 (39)# 45 (52) 8 (36) 10 (22) 3 (19) 2 (40)
Charlson-CI = 1, n 
(%)
38 (22)# 19 (22) 6 (27) 11 (24) 2 (13) 0 (0)
Charlson-CI ≥ 2, n 
(%)




20 (3) 20 (2) 20 (2) 19 (3) 17 (7) 18 (3)
LoS acute hospital in 
days, median (IQR)
19 (14) 19 (11) 19 (13) 19.5 (18) 22 (18) 21 (21)
Barthel Index on 
admission, median 
(IQR)
12 (10)* 14 (7) 9 (12) 9 (8) 8 (9) 10 (6)
Variables at discharge
LoS rehabilitation 
in weeks, median 
(IQR)
12 (15)* 8 (6) 16 (23) 22 (26) – 16 (6)
Barthel Index at 
discharge, median 
(IQR)
17 (8)* 18 (4) 16 (9) 11 (10) – 15 (4)
Relative functional 
gain, median (IQR)
67 (90)* 85 (84) 67 (76) 24 (79) – 71 (42)
Discharge home, n 
(%)
88 (56)# 62 (73) 9 (43) 13 (28) – 4 (80)
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assessment method similar to ours (i.e. 30–54%) [5, 8, 
9, 13, 14, 17]. However, although other studies found a 
higher rate (60–100%), there was a clear difference in the 
methods used. For example, shoulder pain, limb spasticity, 
dysphagia or aphasia were categorised as a complication, 
whereas in the present study (and similar studies) these 
were considered to be symptoms and not diseases [6, 7, 
10–12, 26]. In this study, we were specifically interested 
in intercurrent diseases that occurred during the inpatient 
rehabilitation period, and physicians retrospectively regis-
tered the intercurrent diseases. Nevertheless, our incidence 
rates were similar to those in studies using prospective 
assessment and similar prevalent diseases were found, i.e. 
genitourinary (urinary tract infections) and psychiatric dis-
eases (depression and delirium) [6–12, 14, 17]. However, 
in the present study intercurrent cardiovascular disease 
was more prevalent, presumably because pre-existing 
cardiovascular comorbidities were highly prevalent in our 
subgroup of vulnerable geriatric patients.
Intercurrent diseases and their associations
The presence of intercurrent diseases was related to reha-
bilitation impact indices (longer LoS, less functional 
recovery and less often being discharged home). Despite 
that physicians retrospectively registered intercurrent dis-
eases according to their influence on rehabilitation, it was 
striking that this relation also applied to the category ‘No 
impact’. This underlines the impact that intercurrent dis-
eases can have on rehabilitation outcomes. Besides base-
line functional status and comorbidity in general, diabetes 
mellitus was found to be a significant determinant of the 
occurrence of an intercurrent disease. Diabetes affects 
various organ systems (e.g. vascular, skin, eyes, nervous 
system) and might be the (underlying) cause of a variety 
of intercurrent diseases. However, the present study had 
insufficient power to further investigate different comor-
bidities and their associations with specific intercurrent 
diseases.
Table 2  Associations between 
comorbid conditions and 
presence of ≥ 1 intercurrent 
disease (ID)
Comorbidities included in the logistic regression analysis are presented in bold
Chi Square test: * p < 0.10, # p < 0.05
Comorbidity Total ID absent ID present
Charlson index, median (IQR) 1 (2) 0 (2)# 2 (3)#
Comorbid condition
Myocardial infarction, n (%) 31 (18) 13 18
Heart failure, n (%) 29 (17) 10* 19*
Peripheral vascular disease, n (%) 23 (13) 9 14
Dementia, n (%) 1 (1) 1 0
Chronic pulmonary disease, n (%) 18 (10) 8 10
Musculoskeletal/connective tissue, n (%) 9 (5) 2* 7*
Ulcers, n (%) 8 (5) 2 6
Mild liver disease, n (%) 3 (2) 1 2
Kidney disease (moderate), n (%) 16 (9) 3# 13#
Diabetes mellitus, n (%) 31 (18) 9# 22#
Malignancy, n (%) 10 (6) 3 7
Leukaemia, n (%) 1 (1) 1 0
Lymphoma, n (%) 2 (1) 0 2
Moderate liver disease, n (%) 0 (0) 0 0
Metastasis of solid tumour, n (%) 3 (2) 1 2
Any malignancy (of the above mentioned), n (%) 13 (7) 4 9
Table 3  Comorbidity and baseline function: the separate and com-
bined effect on developing an intercurrent disease in geriatric stroke 
rehabilitation (n = 170)
Charlson-CI charlson comorbidity index, BI Barthel index; CI confi-
dence interval
*Assessing the BI on admission was not possible in 5 patients. Sen-
sitivity analysis showed similar results: when deceased patients were 








Odds ratio [95% CI]
Yes No
No No 6 17 Reference 1.00
No Yes 16 28 1.62 [0.53–4.94]
Yes No 11 18 1.73 [0.52–5.72]
Yes Yes 52 22 6.70 [2.33–19.2]
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Comorbidity and functional impairment
The last aim was to focus on comorbidity and functional 
impairment, as both seem to play an important role in rela-
tion to the occurrence of intercurrent diseases. Moreover, 
our results suggest that the combination of these factors 
increases the risk of developing intercurrent diseases, even 
more than would be expected (i.e. the ORs from the separate 
factors multiplied or summed up). This may indicate that 
the evaluation of comorbidity and functional status should 
be integrated, preferably taking into account the functional 
severity of each comorbid condition. It should be noted that 
some ORs were not significant due to the small size of the 
subgroups. A larger study is needed to further investigate 
this combined effect on developing intercurrent diseases dur-
ing rehabilitation.
Strengths and limitations
The strength of the GRAMPS study is its multidisciplinary 
and multicenter prospective design in a relatively large study 
population. Whereas most studies on stroke rehabilitation 
investigated mainly younger patients, the present study rep-
resents the older, geriatric stroke patient population rela-
tively well and, therefore, strengthens external validity [27]. 
The study investigated two outcomes: presence and num-
ber of intercurrent diseases. Diseases were recorded using 
the ICD-10 coding system, and only diseases were scored 
(i.e. not symptoms such as pain or dysphagia). We believe 
this prevents confusion regarding definitions and elucidates 
the role of functional activities (functional status), medical 
health conditions (comorbidity and intercurrent diseases) 
and their interactions in the complex setting of rehabilita-
tion and recovery, using the ICF model as a framework [28].
Another strength is the use of a Poisson regression that 
allowed to analyse the ‘number of intercurrent diseases’. 
Furthermore, we presented the classifications ‘No impact’ 
and ‘With impact’. The intercurrent diseases found in this 
study might be a selection of the more severe diseases, due 
to the retrospective design of registering the diseases; how-
ever, analysing the impact classification as separate groups 
provided extra information and insight.
Some limitations of the study need to be considered. This 
study can be considered a secondary analysis, because the 
GRAMPS study sample size (power) estimation was origi-
nally based on the dichotomous outcome measure ‘home 
discharge’, and a minimum group size of 70 was considered 
to be appropriate (15). However, in the present study, the 
groups with and without intercurrent disease were of suf-
ficient size (n = 89 and n = 86, respectively). Furthermore, 
the cohort was a specific subgroup of older and vulnerable 
stroke patients as presented in Supplement material Appen-
dix0020A, and data collection for the GRAMPS study ended 
some years ago (in 2010). The mean LoS in this study was 
longer (i.e. ± 4 weeks) compared with recent clinical practice 
in similar SNFs. Nevertheless, we believe that these data 
reflect the current situation of geriatric stroke rehabilitation 
well enough, since no important changes regarding comor-
bidities or intercurrent diseases are expected.
Finally, comorbidity was assessed using the Charlson-CI 
in relation to outcomes other than mortality, although the 
index was specifically designed to predict mortality. Nev-
ertheless, all detected relations showed similar results after 
performing sensitivity analyses in which deceased patients 
were excluded.
Conclusions
Intercurrent diseases frequently occur during geriatric stroke 
rehabilitation and have a detrimental effect on rehabilitation 
outcome, such as functional recovery and length of stay. 
The present study emphasises that comorbidity and func-
tional status need to be integrated and are important factors 
associated with intercurrent diseases. In particular, diabetes 
mellitus showed a strong independent association; there-
fore, this should be a focus for screening, early detection of 
dysregulation and treatment, to target prevention of various 
intercurrent diseases. The impact of specific comorbidities 
and the usefulness of routinely assessing comorbidity com-
bined with integrated functional severity should be further 
investigated.
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